[1]
A. CHADEVE, “A REVIEW ON PHARMACOLOGY AND THERAPEUTIC EFFECTS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Asian J Pharm Clin Res, vol. 13, no. 5, pp. 16–21, May 2020.